Spark Therapeutics to Participate in Multiple Conferences in January

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Spark Therapeutics to Participate in Multiple Conferences in January

Spark Therapeutics (ONCE) PT Lowered to $55 at Goldman Sachs Following US Pricing of Luxturna

January 4, 2018 8:04 AM EST

Goldman Sachs lowered its price target on Spark Therapeutics (NASDAQ: ONCE) to $55.00 (from $58.00) while maintaining a Neutral rating following the company's announcement that US pricing of lead gene therapy Luxturna is at $425K/eye (gross), below GSe of $500K/eye.

Goldman Sachs now... More